These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 17456524)

  • 1. Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.
    Radstake TR; Fransen J; Toonen EJ; Coenen MJ; Eijsbouts AE; Donn R; van den Hoogen FH; van Riel PL
    Ann Rheum Dis; 2007 Nov; 66(11):1525-30. PubMed ID: 17456524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
    Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
    Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility.
    Martínez A; Orozco G; Varadé J; Sánchez López M; Pascual D; Balsa A; García A; de la Concha EG; Fernández-Gutiérrez B; Martín J; Urcelay E
    Hum Immunol; 2007 Sep; 68(9):744-7. PubMed ID: 17869648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients.
    Seitz M; Wirthmüller U; Möller B; Villiger PM
    Rheumatology (Oxford); 2007 Jan; 46(1):93-6. PubMed ID: 16720636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis.
    Baugh JA; Chitnis S; Donnelly SC; Monteiro J; Lin X; Plant BJ; Wolfe F; Gregersen PK; Bucala R
    Genes Immun; 2002 May; 3(3):170-6. PubMed ID: 12070782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
    Cañete JD; Suárez B; Hernández MV; Sanmartí R; Rego I; Celis R; Moll C; Pinto JA; Blanco FJ; Lozano F
    Ann Rheum Dis; 2009 Oct; 68(10):1547-52. PubMed ID: 18930989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
    De Benedetti F; Meazza C; Vivarelli M; Rossi F; Pistorio A; Lamb R; Lunt M; Thomson W; Ravelli A; Donn R; Martini A;
    Arthritis Rheum; 2003 May; 48(5):1398-407. PubMed ID: 12746913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.
    Leech M; Metz C; Hall P; Hutchinson P; Gianis K; Smith M; Weedon H; Holdsworth SR; Bucala R; Morand EF
    Arthritis Rheum; 1999 Aug; 42(8):1601-8. PubMed ID: 10446857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence.
    Meyer-Siegler KL; Vera PL; Iczkowski KA; Bifulco C; Lee A; Gregersen PK; Leng L; Bucala R
    Genes Immun; 2007 Dec; 8(8):646-52. PubMed ID: 17728788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern treatment strategies in rheumatoid arthritis.
    Hetland ML
    Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
    Hetland ML; Christensen IJ; Tarp U; Dreyer L; Hansen A; Hansen IT; Kollerup G; Linde L; Lindegaard HM; Poulsen UE; Schlemmer A; Jensen DV; Jensen S; Hostenkamp G; Østergaard M;
    Arthritis Rheum; 2010 Jan; 62(1):22-32. PubMed ID: 20039405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
    van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Rustenburg F; Baggen JM; Verweij CL; Tak PP
    Ann Rheum Dis; 2008 Apr; 67(4):563-6. PubMed ID: 18042642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register.
    Kristensen LE; Kapetanovic MC; Gülfe A; Söderlin M; Saxne T; Geborek P
    Rheumatology (Oxford); 2008 Apr; 47(4):495-9. PubMed ID: 18316338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug.
    Söderlin MK; Petersson IF; Geborek P
    Scand J Rheumatol; 2012 Feb; 41(1):1-9. PubMed ID: 22118371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids.
    Vivarelli M; D'Urbano LE; Insalaco A; Lunt M; Jury F; Tozzi AE; Ravelli A; Martini A; Donn R; De Benedetti F
    Clin Exp Rheumatol; 2007; 25(5):775-81. PubMed ID: 18078632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIF and TNFα serum levels in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs: a cross-sectional study.
    Brennan-Bourdon LM; De la Cruz-Mosso U; Reyes-Castillo Z; Martínez-Bonilla GE; Ramírez-Dueñas MG; Islas-Carbajal MC; Rincón-Sánchez AR; Salazar-Páramo M; Muñoz-Valle JF
    Immunopharmacol Immunotoxicol; 2015 Apr; 37(2):207-13. PubMed ID: 25721154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
    Listing J; Strangfeld A; Kekow J; Schneider M; Kapelle A; Wassenberg S; Zink A
    Arthritis Rheum; 2008 Mar; 58(3):667-77. PubMed ID: 18311816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy.
    Hizawa N; Yamaguchi E; Takahashi D; Nishihira J; Nishimura M
    Am J Respir Crit Care Med; 2004 May; 169(9):1014-8. PubMed ID: 14962818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis--association with clinical response to glucocorticoids.
    de Paz B; Alperi-López M; Ballina-García FJ; Prado C; Mozo L; Gutiérrez C; Suárez A
    J Rheumatol; 2010 Mar; 37(3):503-11. PubMed ID: 20080912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.